Overall, ProGRP has only moderate sensitivity (~80%) and cannot be used in MTC screening and diagnosis, considering the sensitivity of ~100% robustly demonstrated by either calcitonin or ProCT. The gene discussed is CALCA; the disease is medullary thyroid gland carcinoma.